Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) FCF Margin (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed FCF Margin for 5 consecutive years, with 4236.75% as the latest value for Q2 2025.

  • For Q2 2025, FCF Margin fell 1038.0% year-over-year to 4236.75%; the TTM value through Dec 2025 reached 7979.2%, down 128934.0%, while the annual FY2023 figure was 1192.21%, N/A changed from the prior year.
  • FCF Margin hit 4236.75% in Q2 2025 for Kezar Life Sciences, down from 4956.2% in the prior quarter.
  • Across five years, FCF Margin topped out at 7215.72% in Q4 2021 and bottomed at 290.59% in Q3 2023.
  • Average FCF Margin over 5 years is 4812.04%, with a median of 5187.55% recorded in 2022.
  • Year-over-year, FCF Margin surged 79942bps in 2023 and then crashed -147728bps in 2024.
  • Kezar Life Sciences' FCF Margin stood at 7215.72% in 2021, then crashed by -32bps to 4925.0% in 2022, then plummeted by -106bps to 290.59% in 2023, then surged by 1562bps to 4247.13% in 2024, then dropped by 0bps to 4236.75% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 4236.75%, 4956.2%, and 4247.13% for Q2 2025, Q1 2025, and Q2 2024 respectively.